未来一周收益：PLTR、AMZN、GOOG、AMD、LLY、PEP、F、PFE、MRK、PYPL等

The first full week of February brings a packed earnings calendar, featuring major names across sectors. Tech giants Amazon (AMZN), Alphabet (GOOGL), and AMD (AMD) lead the lineup, while investors will also eagerly watch Palantir (PLTR) and Pfizer (PFE) for growth and guidance updates.

Consumer and media giants PepsiCo (PEP), Disney (DIS) and Ford (F) report alongside PayPal (PYPL). Financials Ares Capital (ARCC) and Prudential (PRU), as well as healthcare leaders Merck (MRK), Amgen (AMGN) and Eli Lilly (LLY) are also in focus.

Other key reports include Philip Morris (PM), Aurora Cannabis (ACB), Canopy Growth (CGC), Simon Property (SPG), ConocoPhillips (COP), Qualcomm (QCOM), Snap (SNAP), Cloudflare (NET), Pinterest (PINS) Honeywell (HON), Fortinet (FTNT), Take-Two (TTWO), Roblox (RBLX), Chipotle (CMG), AstraZeneca (AZN) and Spotify (SPOT).

Below is a rundown of major quarterly updates anticipated in the week of February 3 to February 7:

Monday, February 3

Palantir Technologies (PLTR)

Palantir Technologies (PLTR) is set to release its earnings report after market close on Monday, with the market expecting a 40% increase in EPS and a 27.5% rise in revenue. Over the past 12 months, shares of the Denver-based software company have soared more than 385%.

Despite this impressive growth, the stock gets a Hold rating from both Wall Street analysts and Seeking Alpha's Quant Rating system.

Recently, Wedbush raised its price target for Palantir to $90 from $75, maintaining an Outperform rating. Analyst Dan Ives attributed this upgrade to growing confidence in the company's AI strategy, noting that recent checks have reinforced the bullish outlook for 2025. 

Seeking Alpha author Yiannis Zourmpanos highlights that DeepSeek’s cost-efficient AI could disrupt the market, benefiting Palantir by accelerating AI adoption. This, in turn, is expected to increase demand for Palantir’s secure, enterprise-grade AI integration, leading Zourmpanos to recommend a Strong Buy.

• Consensus EPS Estimates: $0.11
• Consensus Revenue Estimates: $775.91M
• Earnings Insight: The stock has beaten revenue and EPS expectations in 7 of the past 8 quarters.

Also reporting: NXP Semiconductors N.V. (NXPI), The Clorox Company (CLX), Tyson Foods (TSN), Equity Residential (EQR) and more.

Tuesday, February 4

Alphabet (GOOG) (GOOGL)

Following impressive earnings results from other Magnificent 7 members, such as Meta, Microsoft and Apple, Alphabet (GOOG) (GOOGL) is set to continue the momentum this week with its highly anticipated Q4 results, scheduled for release after the market closes on Tuesday.

Analysts are forecasting a strong performance, expecting a 29% increase in earnings and a 12% rise in revenue. While Seeking Alpha's Quant Rating system maintains a Hold rating on the stock, Wall Street analysts are bullish, with a consensus Buy rating.

Dividend Sensei, a Seeking Alpha Investing Group leader, argues that Alphabet is currently about 15% undervalued, offering the potential for 20%–35% annual returns over the next five years. This blend of minimal risk and high upside makes Alphabet a highly attractive option for long-term investors, with the possibility of 3X to 5X returns.

• Consensus EPS Estimates: $2.13
• Consensus Revenue Estimates: $96.67B
• Earnings Insight: Google has topped EPS and revenue expectations in 6 of the past 8 quarters.

Also reporting: Advanced Micro Devices (AMD), Pfizer (PFE), PayPal Holdings (PYPL), Merck (MRK), PepsiCo (PEP), Amgen (AMGN), Simon Property Group (SPG), Snap (SNAP), Prudential Financial (PRU), Enphase Energy (ENPH), Chipotle Mexican Grill (CMG), Regeneron Pharmaceuticals (REGN), Spotify Technology S.A. (SPOT), Archer-Daniels-Midland Company (ADM), Vodafone (VOD), Electronic Arts (EA), Match Group (MTCH), The Estée Lauder Companies (EL) and more.

Wednesday, February 5

Ford Motor Company (F)

Ford (F) is slated to report its Q4 earnings after the market closes on Wednesday, with analysts projecting a Y/Y EPS increase of approximately 12%.

In Q4, Ford’s total vehicle sales saw a 9% rise, reaching 2,078,832 units with retail sales growing by 17%, driven by a 25% gain in its F-Series retail sales. The F-Series, which remains America’s best-selling truck for the 48th consecutive year, posted a 21% increase in total sales. Additionally, Ford achieved a record in electrified vehicle sales (hybrids, plug-in hybrids, and electric vehicles), with 285,291 units sold, a 38% increase.

Despite the impressive performance, both Wall Street analysts and Seeking Alpha's Quant Rating System currently suggest holding the stock.

The Tradevestor, a Seeking Alpha contributor, also maintains a Hold rating, noting improvements in Ford's free cash flow and debt reduction. However, the company’s dividend growth has stagnated, the analyst said, with the quarterly dividend unchanged at 15 cents since 2022. 

• Consensus EPS Estimates: $0.32
• Consensus Revenue Estimates: $42.83B
• Earnings Insight: Ford has missed EPS and revenue expectations in 3 of the past 8 quarters.

Also reporting: The Walt Disney Company (DIS), QUALCOMM (QCOM), Uber Technologies (UBER), Omega Healthcare Investors (OHI), Ares Capital (ARCC), Medical Properties Trust (MPW), Aurora Cannabis (ACB), GSK (GSK), Novo Nordisk A/S (NVO), Aflac (AFL), MetLife (MET), Toyota Motor (TM), McKesson Corporation (MCK), MicroStrategy (MSTR) and more.

Thursday, February 6

Amazon (AMZN)

E-commerce and cloud giant Amazon (AMZN), one of the most closely watched companies reporting during the week alongside Google, will provide insights on its Q4 after the closing bell on Thursday. Analysts anticipating ~49% Y/Y rise in EPS on the topline growth of 10%.

Looking at the stock performance, Amazon shares have gained about 47.6% over the period of 12 months and almost 7% so far this year. While Wall Street analysts have a consensus Strong Buy rating, the Seeking Alpha Quant Ratings system maintains a Hold rating on the stock.

SA author The Techie rates Amazon (AMZN) as a Buy, citing the company’s e-commerce dominance, which is further bolstered by AI-driven personalization. In The Techie’s opinion, Amazon is set for continued top-line growth and outperformance against the S&P 500, thanks in part to the robust ecosystem Amazon has built through its e-commerce business.

Meanwhile, Ahan Vashi, a Seeking Alpha Investing Group leader, suggests holding the stock. Vashi acknowledges that Amazon has recently surpassed multi-year technical resistance in the $190-$200 range, making his earlier downgrade to "Hold" seem premature. Still, while he remains a long-term admirer of Amazon as a business, Vashi believes that the stock is now overvalued by 20%, and its future returns are likely to align with broader market performance.

• Consensus EPS Estimates: $1.49
• Consensus Revenue Estimates: $187.25B
• Earnings Insight: Amazon has beaten EPS and revenue expectations in 7 of the past 8 quarters.

Also reporting: Bristol-Myers (BMY), Philip Morris International (PM), ConocoPhillips (COP), Pinterest (PINS), Cloudflare (NET), Honeywell International (HON), Roblox (RBLX), Eli Lilly (LLY), AstraZeneca (AZN), Peloton Interactive (PTON), Under Armour (UAA), Fortinet (FTNT), Affirm Holdings (AFRM), GoPro (GPRO), Take-Two Interactive Software (TTWO), Kellanova (K), Yum! Brands (YUM), Expedia Group (EXPE), Peabody Energy Corporation (BTU), Baxter International (BAX), Microchip Technology (MCHP), The Hershey Company (HSY) and more.

Friday, February 7

Canopy Growth (CGC)

Canopy Growth (CGC) is set to report its Q4 earnings on Friday before the market opens, with analysts expecting a ~79% improvement in profits.

Despite this, Seeking Alpha’s Quant Rating system flags CGC as high risk, citing decelerating momentum and negative EPS revisions compared to other healthcare stocks. As a result, it assigns a Strong Sell rating, while Wall Street analysts also recommend selling the stock.

Over the past 12 months, CGC shares have plunged nearly 56%, reflecting ongoing weakness in the cannabis sector. However, SA author Alan Sumler maintains a Hold rating, pointing to the company’s in-line financial results and positive outlook. He attributes the stock’s decline to uncertainty surrounding U.S. cannabis regulations and broader market volatility. Despite these challenges, Sumler expects market conditions to stabilize in February, reinforcing his Hold stance.

• Consensus EPS Estimates: -$0.41
• Consensus Revenue Estimates: $48.52M
• Earnings Insight: The company has beaten revenue expectations in 3 of the past 8 quarters, and EPS expectations only once in that time span.

Also reporting: Himax Technologies (HIMX), Plains All American Pipeline, L.P. Common Units (PAA), Organovo Holdings (ONVO), Kimco Realty Corporation (KIM), Newell Brands (NWL) and more.

More on related stocks:

• 3 Reasons I Bought Google Before Earnings And So Should You
• Bristol-Myers Squibb: Too Valuable Not To Hold This Pharma Gem, But Debt Challenges Remain
• AMD: Long-Term Risk/Reward Is Skewed To The Upside
• Bristol Myers Squibb receives positive CHMP opinion for hepatocellular carcinoma treatment
• Pfizer antibody-drug conjugate Tivdak gains EMA panel endorsement